The retroviral oncoprotein v-Rel is a member of the Rel/ NF-kB family of transcription factors. v-Rel has multiple changes as compared to the proto-oncoprotein c-Rel, and these changes render v-Rel highly oncogenic in avian lymphoid cells. Previous results have shown that three mutant residues in the eleven helper virus-derived Envelope (Env) amino acids (aa) at the N-terminus of v-Rel are required for its full oncogenicity. In this report, we show that these mutant Env aa also enable sequences in the N-terminal half of v-Rel to activate transcription in yeast and chicken cells, under conditions where the analogous sequences from c-Rel either do not or only weakly activate transcription. Removal of the Env aa from v-Rel or site-directed mutations that revert the three mutant residues to the residues present in the Rev-A helper virus Env protein abolish this transactivation ability of v-Rel. Addition of mutant Env aa onto c-Rel is not sucient to fully restore the transactivation function; other sequences in the N-terminal half of v-Rel are needed for full transactivating ability. A C terminallytruncated form of NF-kB p100 (p85), produced in HUT-78 human leukemic cells, also activates transcription in yeast, under conditions where the normal p52 and p100 proteins do not. Furthermore, transcriptional activation by p85 in yeast is likely to occur through N-terminal sequences. Taken together, these results are consistent with a model in which transactivation by N-terminal Rel Homology (RH) domain sequences in oncogenic Rel family proteins is in¯uenced by sequences outside the RH domain. Oncogene (2000) 19, 599 ± 607.
Introduction
The vertebrate Rel/NF-kB family of transcription factors includes c-Rel, RelA (p65), RelB, p50/p105 and p52/p100 (for review, see Ghosh et al., 1998) . Rel/NF-kB transcription factors share an N-terminal domain of approximately 300 aa, called the Rel homology (RH) domain, which contains sequences important for DNA binding, dimerization, interaction with the inhibitor IkB, and nuclear localization. Sequences C-terminal to the RH domain in one class of Rel proteins, including c-Rel, RelA and RelB, are known to contain transcription activation domains. A second class of Rel proteins (p105 and p100) contain C-terminal ankyrin-repeat inhibitory domains, which are not generally thought to contain transactivation domains. Removal of these ankyrinrepeat domains yields DNA-binding subunits (p50 and p52), consisting essentially of sequences of the RH domain. p50 homodimers generally repress transcription; however, when bound to certain DNA sites p50 homodimers undergo a conformational change that enables them to activate transcription (Fujita et al., 1992) .
Rel/NF-kB transcription factors control a wide variety of cellular processes, such as immune and in¯ammatory responses, apoptosis, and growth (for review, see Ghosh et al., 1998) . Furthermore, in several cases, mutant Rel/NF-kB transcription factors are expressed in human B-and T-cell leukemia/lymphoma cells (for review, see Rayet and GeÂ linas, 1999) . In addition, one member of the Rel/NF-kB family, v-Rel, is encoded by the highly oncogenic avian Rev-T retrovirus. Although v-Rel can transform a variety of cell types in vitro, it primarily causes a rapidly fatal leukemia/lymphoma in young chickens (for review, see Gilmore, 1999) . The analysis of many mutants indicates that v-Rel transforms cells by constitutively entering the nucleus, binding to DNA as a homodimer, and activating speci®c target genes (Gilmore, 1999) . However, the relevance of speci®c target genes for v-Relinduced oncogenicity has not been rigorously established.
A number of structural and functional features distinguish v-Rel from c-Rel. First, v-Rel is missing two N-terminal and 118 C-terminal aa as compared to c-Rel (Wilhelmsen et al., 1984) . In both cases, these sequences have been replaced by viral Envelope (Env)-derived aa. The C-terminal deletion in v-Rel removes c-Rel residues involved in transcriptional activation and cytoplasmic retention (Capobianco et al., 1990; Kamens et al., 1990) . In addition to the terminal dierences, there are several internal aa dierences between v-Rel and c-Rel. Two of these changes alter the interaction of v-Rel with the inhibitor IkB-a (Sachdev and Hannink, 1998) , two changes aect DNA-binding speci®city (Nehbya et al., 1997) , two changes abolish caspase-3 cleavage sites (Barkett and Gilmore, 1999) , and one change increases the stability of the v-Rel DNA-binding dimer (Mosialos and Gilmore, 1993) . Many of these changes contribute cooperatively to the oncogenicity of v-Rel.
The 11 N-terminal aa of v-Rel are derived from the Rev-A helper virus Env protein. Within these 11 aa of v-Rel, there are three aa substitutions as compared to the wild-type Rev-A Env protein (Wilhelmsen et al., 1984) . Bhat and Temin (1990) have shown that these three Env mutations contribute to the transforming function of v-Rel: that is, a v-Rel mutant with 11 Rev-A Env aa at its N terminus is tenfold less transforming than wild-type v-Rel. However, no speci®c function has been ascribed to the mutant Env aa at the N terminus of v-Rel.
Previously, we have shown that sequences in the Nterminal half of v-Rel can activate transcription in yeast, and that this activity correlated with the ability of N-terminal mutants to transform avian spleen cells in vitro (Kamens et al., 1990) . In this report, we further characterize the ability of sequences in the N-terminal half of v-Rel to activate transcription. Our results show that the N-terminal Env aa confer upon sequences in the N-terminal half of v-Rel the ability to activate transcription in yeast and chicken cells, under conditions where the analogous sequences from c-Rel either do not activate or only weakly activate transcription. Moreover, the mutant residues in Env are necessary for the ability of N-terminal sequences of v-Rel to activate transcription. To our knowledge, this is the ®rst demonstration that mutations within helper virusderived residues directly in¯uence a speci®c function in a retroviral fusion oncoprotein.
Results

Sequences in the N-terminal half of v-Rel activate transcription in yeast
Full-length v-Rel and c-Rel proteins have previously been shown to activate transcription from kB sitecontaining reporter plasmids in yeast (Kamens and Brent, 1991; Mosialos and Gilmore, 1993; White et al., 1996) . To identify the sequences in v-Rel and in c-Rel that are important for transcriptional activation in yeast, the abilities of various v-Rel and chicken c-Rel proteins to activate transcription from a lacZ reporter plasmid (IgK6) containing six upstream kB sites were analysed. As shown in Figure 1 , full-length chicken c-Rel and full-length v-Rel both activated transcription as compared to the level seen with the empty vector control. Deletion of sequences C-terminal to the RH domain essentially abolished the ability of c-Rel (aa 1 ± 322) to activate transcription from the kB site reporter plasmid. In contrast, the analogous N-terminal half of v-Rel (aa 1 ± 331), lacking the C-terminal sequences known to activate transcription in vertebrate cells (Chen et al., 1999; Richardson and Gilmore, 1991; Sarkar and Gilmore, 1993; Smardova et al., 1995) , activated transcription from the kB site reporter plasmid to approximately the same extent as fulllength v-Rel. The N-terminal sequences of v-Rel (aa 1 ± 331) and c-Rel (aa 1 ± 322) used in the reporter gene assays in yeast can both bind to a kB site to approximately the same extent in an electrophoretic mobility shift assay (data not shown; see also Mosialos and Gilmore, 1993) . Taken together, these results indicate that sequences in the N-terminal half of v-Rel have a unique ability, as compared to c-Rel, to activate transcription in yeast.
To further localize sequences in the N-terminal half of v-Rel that were important for transcription activation in yeast, reciprocal V/C and C/V chimeric proteins were analysed in reporter gene assays. V/C activated transcription, but C/V did not, indicating that aa 1 ± 148 of v-Rel are required for transactivation in yeast.
A GAL4-5'v-Rel protein can also specifically activate transcription in yeast and chicken fibroblasts
To determine whether the N-terminal transactivation domain of v-Rel could function when fused to a heterologous DNA-binding domain, a series of GAL4-Rel fusion proteins were tested for their abilities to activate transcription in yeast (Figure 2a ). C-terminal sequences of chicken c-Rel (GAL4-3'c-Rel) activated transcription most strongly among these proteins (488 b-gal units). However, GAL4-5'v-Rel also activated transcription quite eciently (176 units). In contrast, GAL4 fusion proteins containing the analogous Nterminal sequences of c-Rel (GAL4-5'c-Rel) or the Cterminal sequences of v-Rel (GAL4-3'v-Rel) showed essentially no transactivating ability (below 1 unit), similar to the low level seen with the GAL4 DNAbinding domain alone. Furthermore, a two aa insertion mutation (v-SPW), which abolishes the ability of v-Rel to form homodimers and transform chicken spleen cells (Mosialos and Gilmore, 1993; White et al., 1996) , also abolished the ability of GAL4-5'v-Rel to activate transcription. Taken together, these results indicate that sequences in the N-terminal half of v-Rel contain an autonomous transactivation function and they further suggest that this function requires sequences within the RH domain that at least partially overlap with sequences required for the formation of v-Rel homodimers. Previous studies using kB-site reporters have not detected an activation domain in the N-terminal half of v-Rel in vertebrate cells (Kralova et al., 1994; Sarkar and Gilmore, 1993) ; however, this was most likely due to competition with endogenous Rel/NF-kB factors for binding to the kB sites in the reporter plasmids used in those assays. Therefore, to determine whether the Nterminal activation domain of v-Rel could function in vertebrate cells, we analysed the ability of GAL4-Rel fusion proteins to activate transcription from a GAL4 site-containing CAT reporter plasmid in chicken embryo ®broblasts. As shown in Figure 2b , GAL4-5'v-Rel activated transcription approximately 25-fold more eectively than GAL4 sequences alone. The analogous GAL4-5'c-Rel protein was much less ecient than GAL4-5'v-Rel at activating transcription (i.e., about fourfold activation). As a positive control, GAL4-3'v-Rel, containing the C-terminal sequences of v-Rel, activates transcription in CEF (Figure 2b ; Sarkar and Gilmore, 1993) .
The results presented in Figure 2 show that sequences in the N-terminal half of v-Rel activate transcription more eectively than the analogous sequences from c-Rel in both yeast and CEF. In contrast, the C-terminal sequences of v-Rel behave dierently in yeast and CEF: that is, sequences in the C-terminal half of v-Rel activate transcription in CEF, but not in yeast. 
N-terminal Env aa of v-Rel are necessary for transcriptional activation
The ability of the chimeric V/C protein to activate transcription (Figure 1) suggested that either the presence of 11 Env aa at the N terminus of v-Rel or one of the three single aa dierences between v-Rel and c-Rel in the region contained in V/C was necessary for the ability of v-Rel to activate transcription in yeast. To address this issue, we created an expression plasmid for a GAL4 fusion protein (GAL4-5'Env-c-Rel) in which the 11 Env aa of v-Rel were added at the Nterminus of 5'c-Rel. As shown in Figure 3a , GAL4-5'Env-c-Rel activated transcription to a much greater extent than the analogous GAL4-5'c-Rel protein lacking the Env aa. Furthermore, removal of the Env aa from GAL4-5'v-Rel abolished its ability to activate transcription (protein GAL4-5'DEnv-v-Rel).
These GAL4 fusion proteins were also tested for their abilities to activate transcription from a GAL4 site reporter plasmid in CEF (Figure 3b ). In CEF, removal of the Env aa from GAL4-5'v-Rel reduced its ability to activate transcription to a level (about fourfold) similar to that of GAL4-5'c-Rel. Addition of Env aa onto 5'c-Rel (GAL4-5'Env-c-Rel) increased its ability to activate transcription (to about 12-fold). Therefore, in yeast and CEF, the 11 Env aa can enable N-terminal RH domain sequences of v-Rel and c-Rel to activate transcription. Furthermore, removal of the Env aa from 5'v-Rel also abolished its ability to activate transcription from a kB site reporter in yeast (Figure 4 ).
Differences between v-Rel and c-Rel in the Rel homology domain contribute to transactivation by N-terminal sequences of v-Rel
Although the addition of the v-Rel Env aa onto the N terminus of c-Rel enhanced its ability to activate transcription, GAL4-Env-c-Rel did not activate transcription as strongly as GAL4-5'v-Rel in either yeast or CEF, indicating that some other dierence(s) between v-Rel and c-Rel contribute to transcription activation. To map other N-terminal sequences that contribute to activation by v-Rel, we analysed transactivation by GAL4 fusion proteins containing Env aa and various parts of c-Rel and v-Rel. As shown in Figure 3a ,b, GAL4 fusion proteins containing both the Env aa and sequences towards the C terminus of the v-Rel activated transcription nearly as eectively as GAL4-5'v-Rel in yeast and CEF (protein GAL4-5'EnvC/V). Furthermore, v-Rel residues between aa 50 and 148 also enhanced transactivation in the presence of Nterminal Env aa (compare proteins GAL4-5' V/C (Sca) and GAL4-5' V/C (Cla)). Therefore, in yeast and in CEF, the ability of aa 1 ± 331 of v-Rel to activate transcription appears to be primarily dependent on Nterminal Env aa, but requires cooperation with other v-Rel-speci®c sequences within the RH domain.
Mutations within the viral Env sequences of v-Rel are essential for its ability to activate transcription Within the 11 Env aa at the N terminus of v-Rel there are three mutations as compared to the wild-type Env protein of the replication-competent helper virus Rev-A (Wilhelmsen et al., 1984) . To determine whether these mutations were important for activation by Nterminal v-Rel sequences in yeast, we compared the transactivation abilities of GAL4-v-Rel proteins with mutant (GAL4-5'v-Rel) or wild-type Rev-A (GAL4-5' RevA-v-Rel) Env aa (Figure 5a) . Interestingly, the ability of GAL4-5'RevA-v-Rel to activate transcription To demonstrate that the mutations in Env also in¯uence the activity of v-Rel in chicken cells, the same GAL4-Env-Rel proteins were assayed for their transactivation abilities in CEF (Figure 5a ). Similar to the results in yeast, GAL4-5'RevA-v-Rel did not activate transcription above the levels seen with GAL4-5'c-Rel, which is missing the Env aa altogether. The GAL4-5'v-Rel and GAL4-5'RevA-v-Rel proteins were both located exclusively in the nucleus of CEF (Figure 5b) , suggesting that the dierence in their abilities to activate transcription is not due to expression or subcellular localization. Taken together, these results indicate that mutations in the N-terminal Env aa of v-Rel are essential for its N-terminal transactivation function in yeast and chicken cells.
We also compared the DNA-binding activities of v-Rel proteins with normal (mutant) Rev-T Env aa versus introduced Rev-A Env aa at their N termini. v-Rel and the Rev-A-v-Rel proteins were translated in vitro, the amounts of protein were normalized ( Figure  6a, top) , and their abilities to bind to a kB site probe were assessed in an electromobility shift assay ( Figure  6a , bottom). v-Rel and the Rev-A Env v-Rel protein bound the kB site probe to approximately the same extent. Notably, the Rev-A Env v-Rel protein had a slightly reduced mobility as compared to genuine v-Rel on SDS-polyacrylamide gels (Figure 6a , top) and the DNA/protein complex containing the Rev-A Env v-Rel protein had a slightly increased mobility as compared to the normal v-Rel/DNA complex on the nondenaturing EMSA gel (Figure 6a, bottom) . The reduced mobility of the Rev-A Env v-Rel protein on SDS-polyacrylamide gels occurred with v-Rel proteins containing aa 1 ± 331, 1 ± 273 or 1 ± 148 (Figure 6b) .
A truncated nfkb2-encoded p100 protein from a human T-cell lymphoma cell line activates transcription in yeast
The nfkb2 gene, which normally encodes p52/p100 proteins, is frequently rearranged in human lymphoid cancers, such that C terminally-truncated proteins are produced. To determine whether the ability to activate transcription in yeast was a general property of oncogenic Rel family proteins, we compared transactivation in yeast by the truncated p100 protein (p85) from the human cutaneous T-cell lymphoma cell line HUT-78 (Thakur et al., 1994) to the normal p100 and p52 cellular proteins. p85 contains a C-terminal deletion which removes 230 aa, including two of seven ankyrin repeats. For these experiments, cDNAs encoding p52, p100, and p85 were subcloned into a yeast expression vector and their abilities to aect transcription from kB-site reporter plasmid IgK6 were determined. As shown in Figure 7a , p85 had an increased ability to activate transcription from IgK6 as compared to p52 and p100.
To determine whether the C-terminal sequences in p85 could activate transcription, we created GAL4 fusion proteins that contained these C-terminal ankyrin-repeat sequences. These proteins were then analysed for their abilities to activate transcription from a GAL4-site reporter plasmid, as compared to GAL4 sequences alone and GAL4-3'c-Rel (Figure 7b ). Neither GAL4-3'p85 nor GAL4-3'p100 activated transcription much above the GAL4 control sequences alone. Therefore, the C-terminal sequences of p85 do not appear to contain an independent transactivation domain.
Discussion
In this report, we have shown that sequences in the Nterminal half of v-Rel activate transcription in yeast and chicken cells under conditions where the analogous sequences from chicken c-Rel do not. Transcriptional activation by N-terminal v-Rel sequences does not depend on their being directly bound to DNA, as GAL4-v-Rel fusion proteins also speci®cally activate transcription from GAL4 site-containing reporter plasmids. Full transcriptional activation by these v-Rel sequences requires mutant Env sequences at the N terminus of v-Rel and v-Rel-speci®c sequences within the RH domain.
The 11 Env aa at the N terminus of v-Rel have three substitutions as compared to v-Rel. Speci®cally, v-Rel has Phe, Asn, and Phe at positions three, six, and nine, respectively, whereas Rev-A Env has Cys, Asp, and Ser at these positions (Wilhelmsen et al., 1984) . Bhat and Temin (1990) extensively analysed the contribution of the 11 mutant N-terminal Env aa to transformation by v-Rel; mutation of the Env aa in v-Rel to those of the Rev-A helper virus reduced the transforming eciency of v-Rel by tenfold. The Env mutations in v-Rel appear to contribute cooperatively to the transforming function of v-Rel, as no single aa change is sucient to endow a Rev-A Env Rel protein with a transforming ability equal to that of v-Rel; however, the two Phe residues at positions three and nine of v-Rel appear to be especially important for the It is clear that the N-terminal mutant Env aa are not absolutely essential for the transforming activity of mutant Rel proteins. That is, chicken c-Rel proteins with only a C-terminal deletion can transform chicken spleen cells fairly eciently (HrdlicÏ kovaÂ et al., 1994; Kamens et al., 1990; Sachdev and Hannink, 1998) and removal of the Env aa from the N terminus of v-Rel lessens, but does not abolish, its transforming activity (Bhat and Temin, 1990; Garson et al., 1990; Nehyba et al., 1997) . However, the original Rev-T isolate almost certainly did contain Rev-A Env aa at the N terminus of v-Rel, and thus, the Env mutations were likely selected based on their ability to enhance the oncogenicity of the original Env-Rel oncoprotein.
Indeed, the original isolate of Rev-T was less oncogenic than later passages of the virus (Rice and Gilden, 1988) .
Our demonstration that a GAL4 fusion protein containing aa 1 ± 331 of v-Rel (GAL4-5'v-Rel) can activate transcription in yeast and CEF is consistent with several previous reports that indicate that Rel family proteins can activate transcription even if not directly bound to DNA (Curristin et al., 1997; Sif et al., 1993; Xu and GeÂ linas, 1997) . For example, v-Rel can interact with cellular transcription factor Sp1 to activate transcription, and this activity of v-Rel requires N-terminal sequences but is not dependent on the ability of v-Rel to bind to DNA (Sif et al., 1993; Sif and Gilmore, 1994) . Furthermore, although chicken c-Rel can interact with Sp1, it only weakly enhances transactivation by Sp1 (Sif et al., 1993; Sif and Gilmore, 1994) . Thus, the N-terminal activity that we have described here may be important for the ability of v-Rel to enhance transcription from DNA sites to which it cannot directly bind. Our results also show that a truncated version of human p100 (p85) from the HUT-78 leukemic cell line can activate transcription of a kB-site reporter gene in yeast, whereas normal versions of p100 (p52 and p100) cannot. Using human NTera-2 cells, Chang et al. (1995) have also shown that p85 (and not p52 or p100) can activate transcription from a kB-site reporter plasmid and that this ability is dependent on sequences C-terminal to the RH domain. Although NF-kB p100 does not ordinarily bind to DNA, due to its intact set of C-terminal ankyrin repeats, it is likely that p85 and p52 would both bind to DNA in yeast and rat cells (Chang et al., 1995; Thakur et al., 1994) . Therefore, we consider three possibilities for the distinct ability of p85 to transactivate: (1) the additional C-terminal sequences in p85 contain an activation domain; (2) the additional C-terminal sequences in p85 and sequences within the RH domain cooperate to form a transactivation domain; or (3) the C-terminal sequences aect the conformation of the RH domain such that it can now activate transcription. Our analysis of GAL4 fusion proteins (Figure 7b) suggests that the C-terminal sequences of p85 do not contain a transcription activation domain. Moreover, Chang et al. (1995) showed that the addition of bacterial sequences at the C terminus of p52 enabled it to activate transcription. Therefore, we consider it more likely that the abnormal C-terminal sequences in p85 cooperate with RH domain sequences or aect the conformation of the RH domain, such that a transactivation function is exposed.
The mutant Env aa at the N terminus of v-Rel also appear to cooperate with or aect sequences within the RH domain such that a transactivation domain is created. We have no evidence that a conformational change within the RH domain is induced by the mutant Env sequences. For example, the altered mobility of the Rev-A Env v-Rel protein on SDSpolyacrylamide gels does not depend on an intact structure of the RH domain, as deletions that remove C-terminal sequences of the RH domain, including ones important for dimerization, still generate proteins with altered mobilities (Figure 6b) . Moreover, we have Transcriptional activation by the indicated GAL4-fusion proteins was determined as described for Figure 2 . b-galactosidase units are the averages of values from ®ve independent yeast transformants not detected dierences in the trypsin sensitivity of v-Rel and Rev-A Env-Rel or DNA-bound complexes containing these two proteins (data not shown). Therefore, the slight dierences in migration of the Env-Rel proteins and the Rel/DNA complexes on polyacrylamide gels may be due to charge or hydrophobicity dierences between the Env aa in v-Rel and Rev-A Env-Rel, and may not be relevant to the dierences in the transactivation and transforming activities of these proteins.
In summary, alterations outside the RH domain (mutant Env aa in the case of v-Rel and mutant Cterminal sequences in the case of HUT-78 p85) that cooperate with sequences in the RH domain to activate transcription may be a common feature of some oncogenic Rel family proteins. Direct comparisons of the structures of v-Rel and c-Rel and of p52 and p85 may shed light of the mechanisms that underlie the transactivation dierences between the normal and oncogenic versions of these proteins.
Materials and methods
Plasmids
Two yeast lacZ reporter plasmids were used in this study: IgK6, which is a high-copy URA3-containing plasmid that contains six kB sites (from the mouse k light chain locus (Pierce et al., 1988) ) subcloned into the XhoI site of plasmid L252 (Guarente and Ptashne, 1981) , and SD5-Leu, which is a high-copy LEU2-containing plasmid that contains upstream GAL4 binding sites (a kind gift of S Berger; Guarente et al., 1982; Wang et al., 1999) . Yeast expression plasmids were GBT9 (Clontech) for the expression of GAL4 fusion proteins and BC102-Spe/Sna, which is a modi®ed version of plasmid BC102 (Kamens and Brent, 1991; Mosialos and Gilmore, 1993) in which an arti®cial linker was used to insert SpeI and SnaBI sites at the EcoRI site, for the expression of Rel proteins. G5BCAT is a vertebrate cell GAL4-site CAT reporter plasmid (Lillie and Green, 1989) , and SG424 is a vertebrate cell expression plasmid for GAL4 fusion proteins (Sadowski and Ptashne, 1989) .
All yeast and vertebrate cell expression plasmids were made by conventional subcloning techniques (Sambrook et al., 1989) . Fragments containing the sequences shown in ®gures were subcloned into polylinker sites downstream of the GAL4 (1 ± 147) sequences (for GBT9-and SG424-derived plasmids) or as intact cDNAs into the polylinker site of BC102 or BC102-Spe/ Sna for the expression of non-fusion proteins. Where necessary (e.g., as with GAL4 fusion proteins or fragments ampli®ed by PCR), the relevant subclones were con®rmed by DNA sequencing. Details for the construction of all plasmids are available on request or can be obtained at http://people.bu.edu/ gilmore/appendix.html.
Reporter gene assays in yeast
For yeast reporter gene assays, single transformants were picked and used to inoculate 5 ml of liquid media. Cultures were grown at 308C to an OD 595 of 0.4 ± 0.7. 0.5 ml of cultures were pelleted, and cells were resuspended in 200 ml of 0.1 M Tris-HCl, pH 7.0, containing 0.05% Triton X-100. Cells were lysed by freeze/thawing 5 ± 6 times. Yeast liquid bgalactosidase assays were then performed as described previously (Morin et al., 1993; Mosialos and Gilmore, 1993) .
Reporter gene assays in CEF
For CAT reporter gene assays in CEF, cells were transfected by the DMSO-polybrene method as described previously (Sarkar and Gilmore, 1993) with 5 mg of GAL4-site CAT reporter plasmid G5BCAT, 5 mg of the appropriate SG424-based GAL4-fusion producer plasmid, and 0.5 mg of plasmid CMV-lacZ as an internal normalization plasmid. Approximately 36 h later, transfected CEF were scraped, lysed by freeze-thawing, and CAT assays were performed on normalized amounts of cell extracts as described previously (Sarkar and Gilmore, 1993) . CAT assays were detected and quantitated with a Bio-Rad Molecular Imager.
Indirect immunofluorescence
To detect GAL4-fusion proteins by indirect immuno¯uores-cence, CEF were transfected with 10 mg of the indicated plasmids, and 2 days later, CEF were passed onto glass cover slips. Twenty-four hours later, CEF were ®xed with 20% methanol for 10 min, and then stained with a mouse monoclonal primary antibody against the DNA-binding domain of GAL4 (1 : 80; Clontech Laboratories, Inc., Palo Alto, CA, USA) and a¯uorescein-conjugated goat antimouse secondary antibody (1 : 80). Cells were imaged using an Olympus confocal microscope.
Electrophoretic mobility shift assay
Plasmids pGEM-5' v-Rel and pGEM-5' RevA-v-Rel (containing the RevA Env aa in place of the v-Rel Env aa) were constructed such that there is a stop codon just after the HincII site. DNA was subjected to coupled in vitro transcription/translation using the SP6 coupled wheat germ system (Promega, Madison, WI, USA) in the presence of Tran 35 S-label (ICN Pharmaceuticals, Irvine, CA, USA). Samples were then electrophoresed on an SDS-polyacrylamide gel, and v-Rel bands were detected with a Bio-Rad (Richmond, CA, USA) Molecular Imager. Equal amounts of 35 S-labeled proteins were then used in an electrophoretic mobility shift assay using a kB site probe as described previously (Sarkar and Gilmore, 1993) . After electrophoresis, the gel was dried and 32 P-labeled samples were detected by phosphorimaging by exposing the gel to a plate, using several pieces of X-ray ®lm to block the 35 S emissions.
